Why Fast-paced Mover Constellium (CSTM) Is a Great Choice for Value Investors

The article highlights an investment strategy dubbed 'Fast-Paced Momentum at a Bargain,' which seeks stocks demonstrating strong recent price momentum and high beta while maintaining attractive valuations. Constellium (CSTM) is presented as a key example, exhibiting a 3% four-week price change, a beta of 1.7, a Zacks Momentum Score of B, and a Zacks Rank #2 (Buy) driven by upward earnings estimate revisions. Notably, CSTM trades at a low Price-to-Sales ratio of 0.27, suggesting it offers significant upside potential despite its established momentum.

Analysis

Constellium (CSTM) is presented as an attractive investment candidate based on a 'Fast-Paced Momentum at a Bargain' screening methodology, which combines technical momentum with value-oriented fundamentals. The stock exhibits positive price momentum, with a 3% gain over the past four weeks and a 2.8% increase over the last twelve weeks. This movement is amplified by a high beta of 1.7, indicating the stock's price moves 70% more than the broader market, which is favorable in a bullish environment. This technical strength is supported by positive analyst sentiment, evidenced by a Zacks Rank #2 (Buy), which is directly attributed to upward revisions in earnings estimates. Crucially, despite these momentum indicators, CSTM is framed as undervalued. Its Price-to-Sales (P/S) ratio stands at a low 0.27, suggesting that investors are paying only 27 cents for each dollar of company sales, which implies significant room for price appreciation before the valuation becomes stretched.

Key Decisions for Investors

• Investors with a 'growth at a reasonable price' (GARP) or momentum-value hybrid approach should consider the case for CSTM, given the compelling combination of positive price action, upward earnings revisions, and a low Price-to-Sales multiple.
• The stock's high beta of 1.7 presents both an opportunity for outsized gains in a rising market and a significant risk of larger losses in a downturn, warranting careful position sizing and risk management.
• The continuation of upward earnings estimate revisions is a critical pillar of this investment thesis; investors should monitor analyst ratings for any negative shifts, which could signal a potential reversal in momentum.